Somatropin - JCR Pharmaceuticals

Drug Profile

Somatropin - JCR Pharmaceuticals

Alternative Names: Growject; JR-142; JR-401A; JR-401S; JR-401X; Somatropin-long-acting - JCR Pharmaceuticals

Latest Information Update: 05 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator JCR Pharmaceuticals; Savient Pharmaceuticals
  • Developer JCR Pharmaceuticals
  • Class Growth hormones; Hormonal replacements; Obesity therapies
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Short stature
  • New Molecular Entity No

Highest Development Phases

  • Marketed Short stature; Somatotropin deficiency
  • Preclinical Growth disorders

Most Recent Events

  • 04 Jul 2018 Phase-III clinical trials in Short stature in Japan (SC) (JapicCTI-183946)
  • 18 May 2018 JCR Pharmaceuticals plans a phase III trial for Short stature (short stature homeobox-containing gene deficiency) in Japan in July 2018
  • 06 Nov 2015 Preclinical trials in Growth disorders in Japan (unspecified route) (long-acting somatropin)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top